0000000000308936

AUTHOR

Angela Emser

showing 7 related works from this author

Frequency, Risk-Factors and Survival of Children With Atypical Teratoid Rhabdoid Tumors (AT/RT) of the CNS Diagnosed between 1988 and 2004, and Regis…

2011

Purpose To analyze the frequency, prognostic factors, and outcome of children with atypical teratoid/rhabdoid tumors (AT/RT), a rare and highly malignant embryonal brain tumor. Materials and Methods Clinical data of patients diagnosed between 1988 and 2004 with AT/RT who were registered to the German HIT trial center, were correlated with outcome. Patient numbers for AT/RT were compared to numbers for primitive neuroectodermal tumors and medulloblastomas (PNET/MB) registered to the population-based HIT trials. Results We identified 56 patients with the centrally confirmed histopathological diagnosis of AT/RT with a median age of 1.2 years (range, 0.1–14.0 years). The AT/RT:PNET/MB ratio was…

Oncologyeducation.field_of_studymedicine.medical_specialtyChemotherapyPediatricsMultivariate analysisbusiness.industrymedicine.medical_treatmentIncidence (epidemiology)PopulationBrain tumorHematologyDiseasemedicine.diseaseOncologyInternal medicinePediatrics Perinatology and Child HealthAtypical teratoid rhabdoid tumormedicineeducationbusinessSurvival analysisPediatric Blood & Cancer
researchProduct

Longitudinal Study on Growth and Body Mass Index before and after Diagnosis of Childhood Craniopharyngioma

2004

Abstract We analyzed whether childhood craniopharyngioma predisposes to obesity and growth impairment. Height/length, body mass index (BMI), and hypothalamic involvement were evaluated in 90 patients at standardized ages and time points before, after, and at the time of diagnosis. Relevant decreases in height sd score (SDS) started at 10–12 months of age and persisted until diagnosis of childhood craniopharyngioma. Relevant increases in BMI SDS were detectable between 4 and 5 yr of age. Postoperative BMI SDS (yr 1–6) had a weak positive correlation with BMI SDS at the time of diagnosis. In linear regression analysis, hypothalamic tumor involvement (P < 0.001), ponderal index at birth…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismClinical BiochemistryHypothalamusPituitary neoplasmBiochemistryBody Mass IndexCraniopharyngiomaChild DevelopmentEndocrinologyRisk FactorsInternal medicinemedicineHumansNeoplasm InvasivenessPituitary NeoplasmsLongitudinal StudiesObesityRisk factorGrowth DisordersRetrospective Studiesbusiness.industryBody WeightBiochemistry (medical)Childhood CraniopharyngiomaInfantmedicine.diseaseObesityBody HeightCraniopharyngiomaEndocrinologyEl NiñoMultivariate AnalysisHypothalamic NeoplasmDisease SusceptibilitybusinessBody mass indexThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Oral topotecan in children with recurrent or progressive high-grade glioma: a Phase I/II study by the German Society for Pediatric Oncology and Hemat…

2004

BACKGROUND Continuous oral treatment with topotecan may be more effective than the typical 1-day and 5-day treatment schedules. In previous studies of continuous treatment with topotecan, increased intestinal side effects were reported in adult patients; however, the experience in pediatric patients and patients with high-grade glioma is quite limited. METHODS Thirty-two pediatric patients with recurrent high-grade glioma (16 females and 16 males; median age, 9.5 years) were enrolled in the current Phase I/II study. Tumor locations included the cerebral cortex (n = 5), pons (n = 18), and other sites (n = 9). An injectable formulation of topotecan was administered orally, in ice-cold orange …

MaleCancer Researchmedicine.medical_specialtyAdolescentAdministration OralAntineoplastic AgentsGastroenterologyDrug Administration Schedule03 medical and health sciences0302 clinical medicinePharmacokineticsOral administrationInternal medicineGliomaMedicineHumansDosingChild030304 developmental biologyOrange juice0303 health sciencesbusiness.industryBrain NeoplasmsGliomamedicine.disease3. Good healthSurgeryTreatment OutcomeOncology030220 oncology & carcinogenesisChild PreschoolToxicityTopotecanFemalebusinessTopotecanProgressive diseasemedicine.drugCancer
researchProduct

Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: Report from the HIT-LGG 1996 trial

2011

Background We describe demographic data of disseminated childhood low-grade glioma (DLGG) prospectively recruited in the HIT-LGG 1996 study and evaluate the impact of primary chemotherapy (CT) on the outcome of these tumors, which have previously only been described in small and retrospective series. Patients and Methods The multicenter study HIT-LGG 1996 accrued 1181 children and adolescents with low-grade glioma. 61 patients (5.2%) had tumor dissemination, with 2.8% being present at diagnosis. Frequencies of dissemination for different subgroups were calculated. Efficiency of first-line CT with vincristine/carboplatin was defined in 24 children with dissemination prior to first-line non-s…

Oncologymedicine.medical_specialtyVincristineChemotherapybusiness.industrymedicine.medical_treatmentHematologymedicine.diseasePrimary tumorCarboplatinSurgeryRadiation therapychemistry.chemical_compoundOncologychemistryInternal medicineGliomaPediatrics Perinatology and Child HealthmedicinebusinessProspective cohort studySurvival ratemedicine.drugPediatric Blood & Cancer
researchProduct

Influence of photoperiodic history on clock genes and the circadian pacemaker in the rat retina

2006

The influence of seasonal lighting conditions on expression of clock genes and the circadian pacemaker was investigated in the rat retina. For this purpose, the 24-h profiles of nine clock genes (bmal1, clock, per1, per2, per3, dec1, dec2, cry1 and cry 2) and the arylalkylamine N-acetyltransferase gene as an indicator of the circadian pacemaker output were compared between light-dark periods of 8 : 16 and 16 : 8 h. The photoperiod influenced the daily patterns of the amount of transcript for per1, per3, dec2 and arylalkylamine N-acetyltransferase. This indicates that photoperiodic information modulates clock gene expression in addition to the circadian pacemaker of the retina. Under constan…

Maleendocrine systemmedicine.medical_specialtyTime FactorsPhotoperiodGene ExpressionBiologyRetinaRats Sprague-DawleyInternal medicinemedicineAnimalsRNA MessengerEye ProteinsOscillating genephotoperiodismAnalysis of VarianceReverse Transcriptase Polymerase Chain ReactionGeneral NeuroscienceNuclear ProteinsCircadian RhythmRatsPER2CLOCKDEC1PER3EndocrinologyGene Expression RegulationArylalkylamineFemalesense organshormones hormone substitutes and hormone antagonistsPER1European Journal of Neuroscience
researchProduct

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.

2005

The prognosis for young children with medulloblastoma is poor, and survivors are at high risk for cognitive deficits. We conducted a trial of the treatment of this brain tumor by intensive postoperative chemotherapy alone.After surgery, children received three cycles of intravenous chemotherapy (cyclophosphamide, vincristine, methotrexate, carboplatin, and etoposide) and intraventricular methotrexate. Treatment was terminated if a complete remission was achieved. Leukoencephalopathy and cognitive deficits were evaluated.Forty-three children were treated according to protocol. In children who had complete resection (17 patients), residual tumor (14), and macroscopic metastases (12), the five…

medicine.medical_specialtyVincristineCyclophosphamidemedicine.medical_treatmentIntelligenceBrain tumorNeuropsychological TestsCarboplatinchemistry.chemical_compoundAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansCerebellar NeoplasmsCyclophosphamideEtoposideEtoposideProportional Hazards ModelsMedulloblastomaPostoperative CareChemotherapyAnalysis of Variancebusiness.industryDesmoplastic medulloblastomaRemission InductionInfantGeneral Medicinemedicine.diseaseSurvival AnalysisCarboplatinSurgeryMethotrexatechemistryChemotherapy AdjuvantVincristineChild PreschoolNeoplasm Recurrence Localbusinessmedicine.drugFollow-Up StudiesMedulloblastomaThe New England journal of medicine
researchProduct

Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy

2008

To investigate the utility of postoperative chemotherapy in delaying radiotherapy and to identify prognostic factors in early childhood medulloblastoma, we studied children younger than 3 years of age registered to the HIT-SKK'87 (Therapieprotokoll für Säuglinge und Kleinkinder mit Hirntumoren [Brain Tumor Radiotherapy for Infants and Toddlers with Medulloblastoma] 1987) trial who received systemic interval chemotherapy until craniospinal radiotherapy was applied at 3 years of age or at relapse, from 1987 to 1993. Children with postoperative residual tumor or metastatic disease received systemic induction chemotherapy prior to interval chemotherapy. Twenty-nine children were eligible for an…

MaleOncologyCancer Researchmedicine.medical_specialtymedicine.medical_treatmentClinical InvestigationsBrain tumorAntineoplastic AgentsPilot ProjectsDisease-Free SurvivalInternal medicineHumansMedicineProgression-free survivalCerebellar NeoplasmsSurvival rateMedulloblastomaChemotherapybusiness.industryInfantInduction chemotherapyPrognosismedicine.diseaseCombined Modality TherapyChemotherapy regimenSurgerySurvival RateRadiation therapyTreatment OutcomeOncologyChild PreschoolFemaleNeurology (clinical)Cranial IrradiationNeoplasm Recurrence LocalbusinessMedulloblastomaNeuro-Oncology
researchProduct